Explore >> Select a destination
|
You are here 
|
www.fda.gov | ||
| | | | |
18f.gsa.gov
|
|
| | | | | ||
| | | | |
methods.18f.gov
|
|
| | | | | Observing users as they attempt to use a product or service while thinking out loud. | |
| | | | |
aspe.hhs.gov
|
|
| | | | | The National Alzheimer's Project Act (NAPA) creates an important opportunity to build upon and leverage HHS programs and other federal efforts to help change the trajectory of Alzheimer's disease and related dementias (AD/ADRD). The law calls for a National Plan for AD/ADRD with input from a public-private Advisory Council on Alzheimer's Research, Care and Services. The Advisory Council makes recommendations to HHS for priority actions to expand, coordinate, and condense programs in order to improve the ... | |
| | | | |
aspe.hhs.gov
|
|
| | | Insulin prices have increased dramatically over the past decade in the United States. This report presents results from international price comparisons of insulins using a price index approach. The average gross manufacturer price for a standard unit of insulin in 2018 was more than ten times the price in a sample of 32 foreign countries:$98.70 in the U.S., compared with $8.81 in the 32 non-U.S. OECD countries for which we have prescription drug data. The U.S. prices for the mix of insulin used in the U.... | ||
